APO Research

APO RESEARCH · REPORT

Mosapride

Selected research

Market Structure

Global Mosapride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Mosapride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mosapride include DAIICHI SANKYO, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., SAWAI PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma, Konghong Pharmaceutical, HAOSON PHARMA and Lunan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Mosapride market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mosapride and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mosapride revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mosapride market size, projected growth trends, production technologies, key applications, and end-use industries.

Mosapride Segment by Company

DAIICHI SANKYO

Dainippon Pharmaceutical Co., Ltd.

Nihon Generic

NIPPON CHEMIPHAR CO., LTD.

SAWAI PHARMACEUTICAL CO., LTD.

Sumitomo Dainippon Pharma

Konghong Pharmaceutical

HAOSON PHARMA

Lunan Pharmaceutical Group

Mosapride Segment by Type

Tablet

Capsule

Others

Mosapride Segment by Application

Gastritis

Dyspepsia

Others

Mosapride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mosapride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mosapride in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mosapride industry.

Chapter 3: Detailed analysis of Mosapride companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mosapriderevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mosapride Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tablet Table 3. Key Players of Capsule Table 4. Key Players of Others Table 4. Global Mosapride Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Gastritis Table 6. Key Players of Dyspepsia Table 7. Key Players of Others Table 8. Global Mosapride Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Mosapride Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Mosapride Market Share by Region (2021-2026) Table 11. Global Mosapride Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Mosapride Market Share by Region (2027-2032) Table 13. Mosapride Industry Trends Table 14. Mosapride Industry Drivers Table 15. Mosapride Industry Opportunities and Challenges Table 16. Mosapride Industry Restraints Table 17. Global Mosapride Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Mosapride Revenue Market Share by Company (2021-2026) Table 19. Global Mosapride Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Mosapride Key Company Head Office and Area Served Table 21. Global Mosapride Company, Product Type & Application Table 22. Global Mosapride Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Mosapride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Mosapride Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mosapride Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Mosapride Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Mosapride Revenue Market Share by Type (2021-2026) Table 29. Global Mosapride Revenue Market Share by Type (2027-2032) Table 30. Global Mosapride Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Mosapride Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Mosapride Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Mosapride Revenue Market Share by Application (2021-2026) Table 34. Global Mosapride Revenue Market Share by Application (2027-2032) Table 35. DAIICHI SANKYO Company Information Table 36. DAIICHI SANKYO Business Overview Table 37. DAIICHI SANKYO Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. DAIICHI SANKYO Mosapride Product Portfolio Table 39. DAIICHI SANKYO Recent Development Table 40. Dainippon Pharmaceutical Co., Ltd. Company Information Table 41. Dainippon Pharmaceutical Co., Ltd. Business Overview Table 42. Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio Table 44. Dainippon Pharmaceutical Co., Ltd. Recent Development Table 45. Nihon Generic Company Information Table 46. Nihon Generic Business Overview Table 47. Nihon Generic Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Nihon Generic Mosapride Product Portfolio Table 49. Nihon Generic Recent Development Table 50. NIPPON CHEMIPHAR CO., LTD. Company Information Table 51. NIPPON CHEMIPHAR CO., LTD. Business Overview Table 52. NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio Table 54. NIPPON CHEMIPHAR CO., LTD. Recent Development Table 55. SAWAI PHARMACEUTICAL CO., LTD. Company Information Table 56. SAWAI PHARMACEUTICAL CO., LTD. Business Overview Table 57. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio Table 59. SAWAI PHARMACEUTICAL CO., LTD. Recent Development Table 60. Sumitomo Dainippon Pharma Company Information Table 61. Sumitomo Dainippon Pharma Business Overview Table 62. Sumitomo Dainippon Pharma Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sumitomo Dainippon Pharma Mosapride Product Portfolio Table 64. Sumitomo Dainippon Pharma Recent Development Table 65. Konghong Pharmaceutical Company Information Table 66. Konghong Pharmaceutical Business Overview Table 67. Konghong Pharmaceutical Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Konghong Pharmaceutical Mosapride Product Portfolio Table 69. Konghong Pharmaceutical Recent Development Table 70. HAOSON PHARMA Company Information Table 71. HAOSON PHARMA Business Overview Table 72. HAOSON PHARMA Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. HAOSON PHARMA Mosapride Product Portfolio Table 74. HAOSON PHARMA Recent Development Table 75. Lunan Pharmaceutical Group Company Information Table 76. Lunan Pharmaceutical Group Business Overview Table 77. Lunan Pharmaceutical Group Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Lunan Pharmaceutical Group Mosapride Product Portfolio Table 79. Lunan Pharmaceutical Group Recent Development Table 80. North America Mosapride Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Mosapride Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Mosapride Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Mosapride Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Mosapride Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Mosapride Market Size by Country (2021-2026) Table 86. North America Mosapride Market Size by Country (2027-2032) Table 87. Europe Mosapride Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Mosapride Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Mosapride Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Mosapride Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Mosapride Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Mosapride Market Size by Country (2021-2026) Table 93. Europe Mosapride Market Size by Country (2027-2032) Table 94. China Mosapride Market Size by Type (2021-2026) & (US$ Million) Table 95. China Mosapride Market Size by Type (2027-2032) & (US$ Million) Table 96. China Mosapride Market Size by Application (2021-2026) & (US$ Million) Table 97. China Mosapride Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Mosapride Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Mosapride Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Mosapride Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Mosapride Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Mosapride Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Mosapride Market Size by Country (2021-2026) Table 104. Asia Mosapride Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Mosapride Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Mosapride Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Mosapride Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Mosapride Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Mosapride Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Mosapride Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Mosapride Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Mosapride Product Image Figure 2. Global Mosapride Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Mosapride Market Share by Type: 2025 VS 2032 Figure 4. Tablet Image Figure 5. Capsule Image Figure 6. Others Image Figure 7. Global Mosapride Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Mosapride Market Share by Application: 2025 VS 2032 Figure 9. Gastritis Image Figure 10. Dyspepsia Image Figure 11. Others Image Figure 12. Global Mosapride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Mosapride Market Size (2021-2032) & (US$ Million) Figure 14. Global Mosapride Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Mosapride Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Mosapride Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Mosapride Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Mosapride Revenue Market Share by Type (2021-2032) Figure 21. Global Mosapride Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Mosapride Revenue Market Share by Application (2021-2032) Figure 23. North America Mosapride Market Size (2021-2032) & (US$ Million) Figure 24. North America Mosapride Market Share by Type (2021-2032) Figure 25. North America Mosapride Market Share by Application (2021-2032) Figure 26. North America Mosapride Market Share by Country (2021-2032) Figure 27. United States Mosapride Market Size (2021-2032) & (US$ Million) Figure 28. Canada Mosapride Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Mosapride Market Size (2021-2032) & (US$ Million) Figure 30. Europe Mosapride Market Size (2021-2032) & (US$ Million) Figure 31. Europe Mosapride Market Share by Type (2021-2032) Figure 32. Europe Mosapride Market Share by Application (2021-2032) Figure 33. Europe Mosapride Market Share by Country (2021-2032) Figure 34. Germany Mosapride Market Size (2021-2032) & (US$ Million) Figure 35. France Mosapride Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Mosapride Market Size (2021-2032) & (US$ Million) Figure 37. Italy Mosapride Market Size (2021-2032) & (US$ Million) Figure 38. Russia Mosapride Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Mosapride Market Size (2021-2032) & (US$ Million) Figure 40. China Mosapride Market Size (2021-2032) & (US$ Million) Figure 41. China Mosapride Market Share by Type (2021-2032) Figure 42. China Mosapride Market Share by Application (2021-2032) Figure 43. Asia Mosapride Market Size (2021-2032) & (US$ Million) Figure 44. Asia Mosapride Market Share by Type (2021-2032) Figure 45. Asia Mosapride Market Share by Application (2021-2032) Figure 46. Asia Mosapride Market Share by Country (2021-2032) Figure 47. Japan Mosapride Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Mosapride Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Mosapride Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Mosapride Market Size (2021-2032) & (US$ Million) Figure 51. India Mosapride Market Size (2021-2032) & (US$ Million) Figure 52. Australia Mosapride Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Mosapride Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Mosapride Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Mosapride Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Mosapride Market Share by Country (2021-2032) Figure 57. Brazil Mosapride Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Mosapride Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Mosapride Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Mosapride Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Mosapride Market Size (2021-2032) & (US$ Million) Figure 62. UAE Mosapride Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Mosapride Market Size (2021-2032) & (US$ Million) Figure 64. Chile Mosapride Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Others
Applications
  • Gastritis
  • Dyspepsia
  • Others
Companies covered
  • DAIICHI SANKYO
  • Dainippon Pharmaceutical Co., Ltd.
  • Nihon Generic
  • NIPPON CHEMIPHAR CO., LTD.
  • SAWAI PHARMACEUTICAL CO., LTD.
  • Sumitomo Dainippon Pharma
  • Konghong Pharmaceutical
  • HAOSON PHARMA
  • Lunan Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Mosapride Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Capsule
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Mosapride Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Gastritis
  10. 1.3.3 Dyspepsia
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Mosapride Growth Trends by Region
  14. 1.5.1 Global Mosapride Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Mosapride Market Size by Region (2021-2026)
  16. 1.5.3 Mosapride Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Mosapride Market Dynamics
  1. 2.1 Mosapride Industry Trends
  2. 2.2 Mosapride Industry Drivers
  3. 2.3 Mosapride Industry Opportunities and Challenges
  4. 2.4 Mosapride Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Mosapride Revenue by Company (2021-2026)
  2. 3.2 Global Mosapride Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Mosapride Key Company Head office and Area Served
  4. 3.4 Global Mosapride Company, Product Type & Application
  5. 3.5 Global Mosapride Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Mosapride Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Mosapride Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Mosapride Tier 1, Tier 2, and Tier 3
4 Mosapride Market by Type
  1. 4.1 Global Mosapride Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Mosapride Market Size by Type (2021-2032)
  3. 4.3 Global Mosapride Market Size Share by Type (2021-2032)
5 Mosapride Market by Application
  1. 5.1 Global Mosapride Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Mosapride Market Size by Application (2021-2032)
  3. 5.3 Global Mosapride Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 DAIICHI SANKYO
  2. 6.1.1 DAIICHI SANKYO Company Information
  3. 6.1.2 DAIICHI SANKYO Business Overview
  4. 6.1.3 DAIICHI SANKYO Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 DAIICHI SANKYO Mosapride Product Portfolio
  6. 6.1.5 DAIICHI SANKYO Recent Developments
  7. 6.2 Dainippon Pharmaceutical Co., Ltd.
  8. 6.2.1 Dainippon Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio
  12. 6.2.5 Dainippon Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Nihon Generic
  14. 6.3.1 Nihon Generic Company Information
  15. 6.3.2 Nihon Generic Business Overview
  16. 6.3.3 Nihon Generic Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Nihon Generic Mosapride Product Portfolio
  18. 6.3.5 Nihon Generic Recent Developments
  19. 6.4 NIPPON CHEMIPHAR CO., LTD.
  20. 6.4.1 NIPPON CHEMIPHAR CO., LTD. Company Information
  21. 6.4.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
  22. 6.4.3 NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio
  24. 6.4.5 NIPPON CHEMIPHAR CO., LTD. Recent Developments
  25. 6.5 SAWAI PHARMACEUTICAL CO., LTD.
  26. 6.5.1 SAWAI PHARMACEUTICAL CO., LTD. Company Information
  27. 6.5.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
  28. 6.5.3 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio
  30. 6.5.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Developments
  31. 6.6 Sumitomo Dainippon Pharma
  32. 6.6.1 Sumitomo Dainippon Pharma Company Information
  33. 6.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 6.6.3 Sumitomo Dainippon Pharma Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sumitomo Dainippon Pharma Mosapride Product Portfolio
  36. 6.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 6.7 Konghong Pharmaceutical
  38. 6.7.1 Konghong Pharmaceutical Company Information
  39. 6.7.2 Konghong Pharmaceutical Business Overview
  40. 6.7.3 Konghong Pharmaceutical Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Konghong Pharmaceutical Mosapride Product Portfolio
  42. 6.7.5 Konghong Pharmaceutical Recent Developments
  43. 6.8 HAOSON PHARMA
  44. 6.8.1 HAOSON PHARMA Company Information
  45. 6.8.2 HAOSON PHARMA Business Overview
  46. 6.8.3 HAOSON PHARMA Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 HAOSON PHARMA Mosapride Product Portfolio
  48. 6.8.5 HAOSON PHARMA Recent Developments
  49. 6.9 Lunan Pharmaceutical Group
  50. 6.9.1 Lunan Pharmaceutical Group Company Information
  51. 6.9.2 Lunan Pharmaceutical Group Business Overview
  52. 6.9.3 Lunan Pharmaceutical Group Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Lunan Pharmaceutical Group Mosapride Product Portfolio
  54. 6.9.5 Lunan Pharmaceutical Group Recent Developments
7 North America
  1. 7.1 North America Mosapride Market Size (2021-2032)
  2. 7.2 North America Mosapride Market Size by Type
  3. 7.2.1 North America Mosapride Market Size by Type (2021-2026)
  4. 7.2.2 North America Mosapride Market Size by Type (2027-2032)
  5. 7.2.3 North America Mosapride Market Share by Type (2021-2032)
  6. 7.3 North America Mosapride Market Size by Application
  7. 7.3.1 North America Mosapride Market Size by Application (2021-2026)
  8. 7.3.2 North America Mosapride Market Size by Application (2027-2032)
  9. 7.3.3 North America Mosapride Market Share by Application (2021-2032)
  10. 7.4 North America Mosapride Market Size by Country
  11. 7.4.1 North America Mosapride Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Mosapride Market Size by Country (2021-2026)
  13. 7.4.3 North America Mosapride Market Size by Country (2027-2032)
  14. 7.4.4 North America Mosapride Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Mosapride Market Size (2021-2032)
  2. 8.2 Europe Mosapride Market Size by Type
  3. 8.2.1 Europe Mosapride Market Size by Type (2021-2026)
  4. 8.2.2 Europe Mosapride Market Size by Type (2027-2032)
  5. 8.2.3 Europe Mosapride Market Share by Type (2021-2032)
  6. 8.3 Europe Mosapride Market Size by Application
  7. 8.3.1 Europe Mosapride Market Size by Application (2021-2026)
  8. 8.3.2 Europe Mosapride Market Size by Application (2027-2032)
  9. 8.3.3 Europe Mosapride Market Share by Application (2021-2032)
  10. 8.4 Europe Mosapride Market Size by Country
  11. 8.4.1 Europe Mosapride Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Mosapride Market Size by Country (2021-2026)
  13. 8.4.3 Europe Mosapride Market Size by Country (2027-2032)
  14. 8.4.4 Europe Mosapride Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Mosapride Market Size (2021-2032)
  2. 9.2 China Mosapride Market Size by Type
  3. 9.2.1 China Mosapride Market Size by Type (2021-2026)
  4. 9.2.2 China Mosapride Market Size by Type (2027-2032)
  5. 9.2.3 China Mosapride Market Share by Type (2021-2032)
  6. 9.3 China Mosapride Market Size by Application
  7. 9.3.1 China Mosapride Market Size by Application (2021-2026)
  8. 9.3.2 China Mosapride Market Size by Application (2027-2032)
  9. 9.3.3 China Mosapride Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Mosapride Market Size (2021-2032)
  2. 10.2 Asia Mosapride Market Size by Type
  3. 10.2.1 Asia Mosapride Market Size by Type (2021-2026)
  4. 10.2.2 Asia Mosapride Market Size by Type (2027-2032)
  5. 10.2.3 Asia Mosapride Market Share by Type (2021-2032)
  6. 10.3 Asia Mosapride Market Size by Application
  7. 10.3.1 Asia Mosapride Market Size by Application (2021-2026)
  8. 10.3.2 Asia Mosapride Market Size by Application (2027-2032)
  9. 10.3.3 Asia Mosapride Market Share by Application (2021-2032)
  10. 10.4 Asia Mosapride Market Size by Country
  11. 10.4.1 Asia Mosapride Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Mosapride Market Size by Country (2021-2026)
  13. 10.4.3 Asia Mosapride Market Size by Country (2027-2032)
  14. 10.4.4 Asia Mosapride Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Mosapride Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Mosapride Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Mosapride Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Mosapride Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Mosapride Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Mosapride Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Mosapride Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Mosapride Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Mosapride Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Mosapride Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Mosapride Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Mosapride Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Mosapride Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Mosapride Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research